BMO Capital Reiterates Outperform Rating on Arvinas Inc. (ARVN) Following Q3 2022 Earnings

Go back to BMO Capital Reiterates Outperform Rating on Arvinas Inc. (ARVN) Following Q3 2022 Earnings

Arvinas Inc. (ARVN) PT Raised to $81 at Credit Suisse, 'Upgrading ARVN to “Top Pick”'

November 8, 2022 11:42 AM EST

Credit Suisse analyst Richard Law raised the price target on Arvinas Inc. (NASDAQ: ARVN) to $81.00 (from $78.00) while maintaining a Outperform rating.

The analyst comments "ARVN is now our new Top Pick: We maintain our Outperform rating based on ARV471s best-in-class potential as an estrogen... More